Enhanced biosensing strategies using electrogenerated chemiluminescence: recent progress and future prospects

Area of Science:

• Analytical Chemistry
• Biomedical Engineering
• Biotechnology

Background:

• Ultrasensitive bioassays are crucial for early cancer biomarker detection and diagnosis.
• Electrogenerated chemiluminescence (ECL) offers powerful analytical capabilities for sensitive target detection.
• Integrating ECL with immunosensing and aptasensing significantly enhances assay performance.

Purpose of the Study:

• To review recent progress in enhancing and amplifying ECL detection techniques.
• To discuss methods for ECL enhancement using highly sensitive immunosensors and aptasensors.
• To provide an overview of widely popular ECL-based detection techniques.

Main Methods:

• Review of recent scientific literature on ECL assay development.
• Analysis of enhancement and amplification strategies in ECL detection.
• Focus on ECL integration with immunosensing and aptasensing platforms.

Main Results:

• ECL techniques show great potential for ultrasensitive and accurate bioassays.
• Immuno- and aptasensors coupled with ECL offer multiplied advantages for biomarker detection.
• Continuous development aims for improved performance and lower detection limits in ECL assays.

Conclusions:

• ECL-based immunosensors and aptasensors are key for advancing sensitive cancer diagnostics.
• Further research in ECL enhancement is vital for clinical applications.
• These integrated techniques promise more effective early disease detection.